BioSpace News Archive

Celularity Inc., a clinical-stage cell therapeutics company focused on the development of innovative allogeneic placenta-derived cellular therapies, today announced that its Lifebank division has released its 100th cord blood stem cell unit for use in an autologous cord blood transplant to treat an eight-year-old patient diagnosed with autism spectrum disorder.

Today, the Cystic Fibrosis Foundation announced a new award of up to $2 million to Eloxx Pharmaceuticals Inc. to support the global Phase 2 clinical program of ELX-02, a potential therapy to treat people with cystic fibrosis who have nonsense mutations.

Total prescriptions of GOCOVRI of approximately 8,165 for fourth quarter 2020 and approximately 31,070* for full year 2020

Bioclinica, an integrated solutions provider of clinical life science and technology expertise, today announced its partnership with IKCON PHARMA (subsidiary/affiliate of IKCON TECHNOLOGIES INC), a Clinical Research Organization (CRO) & technology services company

Industry-leading smart glasses technology expected to enhance the utility of BioSig’s PURE EP™ System signal processing platform. Remote servicing intended to enable continued installations, upgrades, and training during COVID-19 travel restrictions and lockdown limitations.

Enalare Therapeutics Inc., a clinical stage biopharmaceutical company dedicated to developing novel therapies for patients suffering from acute respiratory conditions, announced today that it has completed formation of its scientific advisory board.

According to the report, the global aseptic transfer system market was valued at ~US$ 892 Mn in 2019 and is projected to expand at a CAGR of 6.5% from 2020 to 2030.

Physical therapy, also known as physiotherapy, is a health profession in which healthcare practitioners treat different human conditions, such as physical impairments experienced by people in the musculoskeletal, cardiovascular, gastrointestinal, neurological, endocrinological, trauma or disease, or birth defects

According to the report, the global respiratory virus infection drugs market was valued over US$ 38.6 Bn in 2019 and is projected to expand at a CAGR of ~7% from 2020 to 2030.

The telerehabilitation system is for patients who live far from actual centers of rehabilitation. It also decreases the regular visits of patients to hospitals and rehabilitation facilities, since, after discharge, doctors are likely to follow up with clients.